The effect of Acupoint Injection on improving insulin sensitivity in PCOS patients of kidney deficiency and blood stasis: a randomized controlled trial

Not Applicable

• Conditions: polycystic ovary syndrome

• Registration Number: ITMCTR2200005645
• Lead Sponsor: Chongqing Traditional Chinese Medicine Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: Not specified

Inclusion Criteria

? Meet the recommendations of the expert meeting of the European Society for human reproduction and embryo and American Society of reproductive medicine (ESHRE / ASRM) in Rotterdam in 2003;
? 18-40 years old;
? Having no intention of pregnancy, taking non-drug contraceptive measures (male using condom) after selection;
? Those who can follow up according to the experimental requirements

Exclusion Criteria

? Persons over 40 years old or under 18 years old;
? Long term or recent application of exogenous androgen; Or being treated with corticosteroids; Or receiving malignant tumor treatment; Or have a history of drug abuse and alcoholism in the past 2 years;
? Those who have used metformin or other insulin sensitizers in the past 1 month;
? Combined with other endocrine diseases: such as hyperprolactinemia, thyroid disease, androgen secreting tumor, Cushing's syndrome, congenital adrenal cortical hyperplasia, etc;
? Those with serious cardiovascular, blood, liver and kidney diseases and low immune function; ALT or AST is higher than the upper limit of normal reference value, and serum creatinine is higher than the upper limit of normal reference value;
? Patients who cannot take effective contraceptive measures during the experiment;
? Patients with other infertility diseases besides PCOS;
? Pregnant and lactating women;
? Patients with a history of mental illness or active mental illness

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
HOMA-IR;

Secondary Outcome Measures

Name	Time	Method
ß-cell function;Plasma lilpid;weight;Plasma glucose;sex hormones;waist;Plasma insulin;HbA1c;